Brief Behavioral Activation Treatment for Depression With Inpatients

An Evaluation of Brief Behavioral Activation Treatment for Depression With Moderate to Severely Depressed Inpatients - A Small Randomized Controlled Trial

The purpose of the current study was to examine Brief Behavioral Activation Treatment for Depressions (BATD) effectiveness, credibility, and acceptability with moderate to severly depressed inpatients. The study is a systematic replication of a randomized controlled trail from 2003, that provided initial support for BATD With inpatients. The current study compared BATD to Treatment as Usual in a randomized controlled trial.

Inclusion Criteria:

• Moderate to severe depression (BDI-II > 28 Points).
• Admission length of at least 3 days
• Evaluated to benefit from depression treatment by unit psychiatrist.

Exclusion Criteria:

• Current psychotic disorder
• Previously diagnosis with psychotic disorder (including Bipolar disorder)